|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
91,540,000 |
Market
Cap: |
34.79(M) |
Last
Volume: |
1,296,467 |
Avg
Vol: |
1,292,882 |
52
Week Range: |
$0.38 - $0.9341 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Curis is a biotechnology company focused on the development of therapeutics for the treatment of cancer. Co.'s clinical stage drug candidates are: Emavusertib, which is being tested in a Phase 1/2 dose escalating clinical trial in patients with non-Hodgkin lymphomas; CI-8993, which is a monoclonal antibody; Fimepinostat, which is a small molecule that potently inhibits the activity of histone deacetylase, and phosphotidyl-inositol 3 kinase; CA-170, for which Co. has announced initial data from a clinical study in patients with mesothelioma in conjunction with the Society of lmmunotherapy of Cancer; and CA-327, which is a small molecule antagonist of PDL1 and TIM3.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mcnab James R |
Director |
|
2012-12-20 |
5 |
GD |
$0.00 |
$0 |
I/I |
30,975 |
100,000 |
|
- |
|
Passeri Daniel R |
CEO and Director |
|
2012-12-06 |
4 |
B |
$3.03 |
$75,750 |
D/D |
25,000 |
150,750 |
2.74 |
- |
|
Greenacre Martyn D |
Director |
|
2012-09-19 |
4 |
S |
$4.31 |
$215,500 |
D/D |
(50,000) |
35,138 |
|
- |
|
Greenacre Martyn D |
Director |
|
2012-09-19 |
4 |
OE |
$1.09 |
$54,500 |
D/D |
50,000 |
85,138 |
|
- |
|
Gray Michael |
COO and CFO |
|
2012-09-18 |
4 |
AS |
$4.28 |
$112,350 |
D/D |
(26,250) |
86,613 |
|
- |
|
Gray Michael |
COO and CFO |
|
2012-09-18 |
4 |
OE |
$1.09 |
$28,613 |
D/D |
26,250 |
112,863 |
|
- |
|
Noel Mark |
VP, Tech Management |
|
2012-08-01 |
4 |
AS |
$4.74 |
$227,520 |
D/D |
(48,000) |
27,540 |
|
- |
|
Noel Mark |
VP, Tech Management |
|
2012-08-01 |
4 |
OE |
$1.09 |
$52,320 |
D/D |
48,000 |
75,540 |
|
- |
|
Mcnab James R |
Director |
|
2012-06-19 |
4 |
S |
$4.76 |
$661,640 |
D/D |
(139,000) |
1,079,688 |
|
- |
|
Mcnab James R |
Director |
|
2012-06-18 |
4 |
S |
$4.75 |
$712,500 |
D/D |
(150,000) |
1,218,688 |
|
- |
|
Mcnab James R |
Director |
|
2012-06-15 |
4 |
S |
$4.73 |
$52,030 |
D/D |
(11,000) |
1,368,688 |
|
- |
|
Gray Michael |
COO and CFO |
|
2012-04-19 |
4 |
AS |
$5.01 |
$12,129 |
D/D |
(2,421) |
86,613 |
|
- |
|
Gray Michael |
COO and CFO |
|
2012-04-19 |
4 |
OE |
$1.50 |
$3,632 |
D/D |
2,421 |
89,034 |
|
- |
|
Gray Michael |
COO and CFO |
|
2012-04-18 |
4 |
AS |
$5.01 |
$202,519 |
D/D |
(40,423) |
86,613 |
|
- |
|
Gray Michael |
COO and CFO |
|
2012-04-18 |
4 |
OE |
$1.50 |
$60,635 |
D/D |
40,423 |
127,036 |
|
- |
|
Greenacre Martyn D |
Director |
|
2012-03-28 |
4 |
S |
$4.92 |
$393,600 |
D/D |
(80,000) |
35,138 |
|
- |
|
Greenacre Martyn D |
Director |
|
2012-03-28 |
4 |
OE |
$1.09 |
$117,950 |
D/D |
80,000 |
115,138 |
|
- |
|
Passeri Daniel R |
CEO and Director |
|
2012-03-20 |
4 |
OE |
$1.09 |
$81,516 |
D/D |
60,750 |
125,750 |
|
- |
|
Tobin James R |
Director |
|
2012-03-08 |
4 |
OE |
$1.09 |
$115,225 |
D/D |
77,500 |
124,251 |
|
- |
|
Bayh Susan B |
Director |
|
2011-12-23 |
4 |
AS |
$4.50 |
$133,673 |
D/D |
(29,705) |
25,000 |
|
- |
|
Bayh Susan B |
Director |
|
2011-12-23 |
4 |
OE |
$1.50 |
$54,746 |
D/D |
29,705 |
54,705 |
|
- |
|
Kaitin Kenneth I |
Director |
|
2011-05-11 |
4 |
B |
$3.68 |
$25,024 |
D/D |
6,800 |
26,800 |
2.39 |
- |
|
Mcnab James R |
Director |
|
2011-03-31 |
4 |
S |
$3.25 |
$81,250 |
D/D |
(25,000) |
1,122,188 |
|
- |
|
Passeri Daniel R |
CEO and Director |
|
2011-03-31 |
4 |
S |
$3.25 |
$318,825 |
D/D |
(98,100) |
65,000 |
|
- |
|
Passeri Daniel R |
CEO and Director |
|
2011-03-31 |
4 |
OE |
$3.13 |
$307,053 |
D/D |
98,100 |
163,100 |
|
- |
|
303 Records found
|
|
Page 5 of 13 |
|
|